BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 4007021)

  • 1. C-reactive protein for detection and follow-up of bacterial and fungal infections in severely neutropenic patients with acute leukaemia.
    Timonen TT; Koistinen P
    Eur J Cancer Clin Oncol; 1985 May; 21(5):557-62. PubMed ID: 4007021
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Significance of interleukin-6 (IL-6) and C-reactive protein (CRP) in children and young adults with febrile neutropenia during chemotherapy for cancer: a prospective study.
    Chaudhary N; Kosaraju K; Bhat K; Bairy I; Borker A
    J Pediatr Hematol Oncol; 2012 Nov; 34(8):617-23. PubMed ID: 22983415
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial study of C-reactive protein for the diagnosis of bacterial and fungal infections in neutropenic patients with hematologic malignancies.
    Venditti M; Brandimarte C; Trobiani P; Fenu S; Martino P; Serra P; Mandelli F
    Haematologica; 1988; 73(4):285-91. PubMed ID: 3139532
    [No Abstract]   [Full Text] [Related]  

  • 4. The differential diagnostic capacity of serum amyloid A protein between infectious and non-infectious febrile episodes of neutropenic patients with acute leukemia.
    Casl MT; Rogina B; Glojnarić-Spasić I; Minigo H; Planinc-Peraica A; Jaksić B
    Leuk Res; 1994 Sep; 18(9):665-70. PubMed ID: 7934141
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum C-reactive protein levels in the management of infection in acute leukaemia.
    Starke ID; de Beer FC; Donnelly JP; Catovsky D; Goldman JM; Galton DA; Pepys MB
    Eur J Cancer Clin Oncol; 1984 Mar; 20(3):319-25. PubMed ID: 6584311
    [TBL] [Abstract][Full Text] [Related]  

  • 6. C-reactive protein concentration as a guide to antibiotic therapy in acute leukaemia.
    Schofield KP; Voulgari F; Gozzard DI; Leyland MJ; Beeching NJ; Stuart J
    J Clin Pathol; 1982 Aug; 35(8):866-9. PubMed ID: 7107959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tobramycin-cephalothin treatment in leukaemic and neutropenic patients with severe infection.
    Papayannis AG; Thomopoulos D; Voulgaris E; Scliros P; Gardikas C
    J Antimicrob Chemother; 1977 Jul; 3(4):311-5. PubMed ID: 893240
    [No Abstract]   [Full Text] [Related]  

  • 8. A prospective study of daily measurement of C-reactive protein in serum of adults with neutropenia.
    Manian FA
    Clin Infect Dis; 1995 Jul; 21(1):114-21. PubMed ID: 7578719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Fever in neutropenic patients: analysis of 109 episodes and 15 superinfections (author's transl)].
    Baro J; Richard C; Esteban J; Iriondo A; Conde E; Garijo J; Zubizarreta A
    Sangre (Barc); 1981; 26(4):417-26. PubMed ID: 7292225
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
    d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
    J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. C-reactive protein and fever in neutropenic patients.
    Arber C; Passweg JR; Fluckiger U; Pless M; Gregor M; Tichelli A; Schifferli JA; Gratwohl A
    Scand J Infect Dis; 2000; 32(5):515-20. PubMed ID: 11055657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein in the diagnosis and management of infections in granulocytopenic and non-granulocytopenic patients.
    Ligtenberg PC; Hoepelman IM; Oude Sogtoen GA; Dekker AW; van der Tweel I; Rozenberg-Arska M; Verhoef J
    Eur J Clin Microbiol Infect Dis; 1991 Jan; 10(1):25-31. PubMed ID: 2009874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Fever in the neutropenic patient].
    Milpied N
    Rev Prat; 2001 Mar; 51(6):633-7. PubMed ID: 11345865
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of procalcitonin, neopterin, C-reactive protein, IL-6 and IL-8 as a diagnostic marker of infection in patients with febrile neutropenia.
    Prat C; Sancho JM; Dominguez J; Xicoy B; Gimenez M; Ferra C; Blanco S; Lacoma A; Ribera JM; Ausina V
    Leuk Lymphoma; 2008 Sep; 49(9):1752-61. PubMed ID: 18661397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stopping antibiotics in neutropenic patients.
    Cheesbrough JS; Murray A
    Ann Intern Med; 1988 Jun; 108(6):908. PubMed ID: 3369786
    [No Abstract]   [Full Text] [Related]  

  • 16. C-reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia.
    Santolaya ME; Cofre J; Beresi V
    Clin Infect Dis; 1994 Apr; 18(4):589-95. PubMed ID: 8038314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Procalcitonin adds to diagnosis, but does not reduce initial antibiotics in febrile neutropenic children.
    Lodahl D; Schrøder H
    Dan Med Bull; 2011 Mar; 58(3):A4233. PubMed ID: 21371399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The predictive and diagnostic values of procalcitonin and C-reactive protein for clinical outcome in febrile neutropenic patients.
    Erten N; Genc S; Besisik SK; Saka B; Karan MA; Tascioglu C
    J Chin Med Assoc; 2004 May; 67(5):217-21. PubMed ID: 15357107
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fever and neutropenia in children with neoplastic disease: an analysis of 158 episodes.
    Nachman JB; Honig GR
    Cancer; 1980 Jan; 45(2):407-12. PubMed ID: 7351024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Timentin in combination with tobramycin as empirical therapy in febrile neutropenic patients with haematological malignancies.
    Krieger O; Bernhart M; Plohowich R; Nemec H; Lutz D
    J Antimicrob Chemother; 1986 May; 17 Suppl C():211-7. PubMed ID: 3636336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.